Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FLUVOXAMINE MALEATE USP, with a corresponding US DMF Number 36303.
Remarkably, this DMF maintains an Active status since its submission on December 01, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 30, 2021, and payment made on November 12, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II